Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization
- 1 April 2010
- Vol. 28 (18) , 3238-3246
- https://doi.org/10.1016/j.vaccine.2010.02.010
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01-AI070976)
This publication has 53 references indexed in Scilit:
- Replicon Particles of Venezuelan Equine Encephalitis Virus as a Reductionist Murine Model for EncephalitisJournal of Virology, 2009
- Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus ChallengeJournal of Virology, 2009
- Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigenVaccine, 2008
- Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirusVaccine, 2007
- Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaVaccine, 2007
- Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type miceVaccine, 2007
- CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organsNature, 2006
- G-CSF: A key regulator of neutrophil production, but that's not all!Growth Factors, 2005
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA cloneVirology, 1991